Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Seeking Alpha

4 Tesla Stock Mistakes That Cost Investors Thousands

Tesla's stock is positive for 2025 despite major setbacks it faced earlier this year. Learn the four costly investor mistakes to avoid before jumping in.

GOBankingRates

This ‘Strong Buy’ Stock Is a Classic – and It Pays a Dividend Too

Ralph Lauren (RL) boasts strong technical momentum and is trading at new all-time highs. Shares have a 100% “Buy” opinion from Barchart and are up 66% over the past year. RL fundamentals are solid, as analysts project revenue and earnings growth. However, there is reason for caution due to Ralph...

Barchart

This Red-Hot Biopharma Stock Could Fizzle Out Soon

Roivant Sciences (ROIV) shows strong technical momentum and is trading at new all-time highs. Shares are up 52% over the past year and 20% in the last month. ROIV has a 100% “Buy” opinion from Barchart and a Trend Seeker “Buy” signal. Despite the price gains, Roivant lacks consistent revenue...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Alphabet Stock Off Its Peak - Is It Undervalued? It Could Be If FCF Stays Strong

Alphabet stock has declined from its recent peak. But is there any significant upside from here? It's possible, especially if its free cash flow (FCF) remains strong. It could be up to 25% too cheap.

Barchart

This ‘Darling’ Pharma Stock Is Hitting New Highs

Rigel Pharmaceuticals (RIGL) is showing exceptional momentum, setting new 52-week highs on Aug. 22. Shares are up nearly 243% over the past year. The stock is trading above key moving averages and is supported by several “Strong Buy” analyst ratings. Fundamentals show impressive projected earnings growth this year, but both...

Barchart

This Penny Stock Has Wall Street's Attention and Is Up Nearly 600%

ImmunoPrecise Antibodies (IPA) shows strong technical momentum, hitting new 52-week highs on Aug. 21. The stock maintains a 100% “Buy” opinion from Barchart. Shares are up an impressive 565% in 2025. Despite bullish analyst sentiment, IPA is volatile and speculative. Today’s Featured Stock Valued at only $121 million, ImmunoPrecise Antibodies...

Barchart

Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap

Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shorting puts works here.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Fiserv Stock Gets Pummeled After Earnings - Looks Cheap Here

Fiserv stock is down over 13% in the last week since its Q2 earnings were released. But was it really all that bad? After all, it generated strong earnings and free cash flow. FI stock looks cheap here.

Barchart

MSCI, the Index Company, Forecasts Strong Free Cash Flow, Looks Undervalued

MSCI, Inc., the stock index company, produced robust Q2 earnings and forecasted strong free cash flow margins. MSCI stock looks deeply undervalued here, and shorting OTM put options for income is a good play.

Barchart

Delta Air Lines Shows Unusual Call Options Ahead of Earnings - Investors are Bullish on DAL Stock

Barchart's Unusual Stock Options Activity Report shows Delta Air Lines (DAL) call options traded today. That is a bullish signal from investors ahead of its Q2 earnings release tomorrow, before the market opens.

Barchart

Constellation Brands Stock is Down But Produced Good Earnings - Is STZ a Buy Here?

Constellation Brands, which sells Corona and Modelo beers, generated lower sales but maintained its free cash flow guidance. STZ stock is down from its highs. Based on its historical averages, it appears to be a bargain.

Barchart

Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook

Large unusual trading volume in Pfizer put options that expire 30 days from now signals investors' bullish outlook on PFE stock. It trades for just over 8 times earnings, well below its 10-year historical average P/E ratio.

Barchart

Nvidia's Free Cash Flow and FCF Margins Skyrocket - NVDA Stock Looks Cheap

Nvidia Inc. reported strong revenue, free cash flow (FCF), and FCF margins. This implies a much higher valuation for NVDA stock - over $191 per share. Short-put plays are also attractive here, and they have high yields.

Barchart

GameStop Stock Could Surge From Here - All Eyes are On Its Results

GameStop Corp. is now solidly free cash flow positive, as its FCF margin last quarter was 12.4% of sales. Its upcoming June 9 results will show how much Bitcoin it may have bought. These two factors could push GME even higher.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Nvidia Earnings This Week - Strong Free Cash Flow and FCF Margins Could Push NVDA Higher

Nvidia will release its fiscal Q1 2026 (ended April 30) after the close on Wednesday, May 28. If free cash flow and FCF margins stay strong, NVDA stock could rise based its value using a 2.0% FCF yield metric.

Barchart

Constellation Brands Stock Looks Cheap and Is Off Its Highs - Is STZ a Buy Here?

Constellation Brands, which sells Modelo and Corona beer, is a strong free cash flow producer. However, STZ stock is well off its highs and has low valuation metrics. Should investors buy it now?

Barchart

Unusual Activity in Nvidia Put Options Ahead of Earnings - Are Investors Still Bullish?

Today, many Nvidia put options in several near-the-money strike prices tranches show investors are positioning ahead of the earnings release in two weeks. Some of these trade show bullish sentiment in NVDA stock with high short-put yields.

Barchart

Alphabet's FCF Results Are Better Than Expected - Time to Buy GOOG?

Alphabet reported higher free cash flow results for Q1 than last year. However, its capex spending surged over 50%, but FCF margins remained high. That makes GOOG stock look cheap here.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Chevron Stock Too Cheap With Its 5.1% Yield After Its Recent Dividend Hike?

Chevron pays an annualized dividend per share of $6.84, so at today's price, CVX stock sports a 5.1 %+ annual dividend yield. Is that too cheap, especially since its average over the last 5 years is well below this?

Barchart

AT&T Has Momentum

Summary AT&T (T) shows strong technical indicators with 100% buy signals, a 62.91% gain in the last year, and is above key moving averages. Fundamental factors include a market cap of $203 billion, a P/E of 12.47, and a dividend yield of 3.93%, with mixed revenue and earnings growth projections....

The Independent UK

Newsmax goes full ‘meme stock’ as shares have surged over 2000 percent since insane IPO debut

‘This is like the initial market reaction to DJT on steroids,’ one investment expert said about the explosive Newsmax rally

Barchart

BP Plc Is Attracting Value Buyers with its 5.69% Dividend Yield and 10x P/E

BP Plc, the oil and gas company, has an attractive 5.69% dividend yield and a low 10x price/earnings multiple. That is attracting value buyers, including short-sellers of out-of-the-money put options.

Barchart

This Stock Is Up Almost 15% YTD and Yields 4.1% With a 15x Forward P/E - Value Investors Love It

Chevron Corp stock is up 14.7% YTD and still looks cheap with a 4.1% dividend yield and a forward price-to-earnings multiple below 15x. Value buyers love this, and many are shorting out-of-the-money puts to gain extra income.

Barchart

Cardinal Health Has a String of New Highs

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing a wide range of healthcare services and products, including pharmaceuticals, medical supplies, and radiopharmaceuticals. Barchart's technical indicators highlight CAH's positive...

Barchart

Hess - Drill Baby Drill

Summary Hess Corporation (HES) shows strong technical indicators with 100% buy signals, a Trend Seeker buy signal, and consistent price appreciation above key moving averages. The company operates in exploration, production, and midstream activities, with significant operations in the U.S., Guyana, and Malaysia. Wall Street analysts provide mixed ratings with...

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.